These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18622799)

  • 1. Lymphocyte recovery: an overlooked contribution to autologous stem cell transplant outcome.
    Le Blanc K
    Cytotherapy; 2008; 10(5):441-2. PubMed ID: 18622799
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Cytotherapy; 2008; 10(5):507-17. PubMed ID: 18608354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions.
    Alegre A
    Bone Marrow Transplant; 2009 Apr; 43(8):593-5. PubMed ID: 19384344
    [No Abstract]   [Full Text] [Related]  

  • 4. Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
    Uy GL; Goyal SD; Fisher NM; Oza AY; Tomasson MH; Stockerl-Goldstein K; DiPersio JF; Vij R
    Bone Marrow Transplant; 2009 May; 43(10):793-800. PubMed ID: 19029964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
    Nakasone H; Kanda Y; Ueda T; Matsumoto K; Shimizu N; Minami J; Sakai R; Hagihara M; Yokota A; Oshima K; Tsukada Y; Tachibana T; Nakaseko C; Fujisawa S; Yano S; Fujita H; Takahashi S; Kanamori H; Okamoto S;
    Am J Hematol; 2009 Dec; 84(12):809-14. PubMed ID: 19862826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
    Rosenbaum C; Peace D; Rich E; Van Besien K
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):719-23. PubMed ID: 18489998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.
    Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL
    Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunotherapy for multiple myeloma.
    Rosenblatt J; Avigan D
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):559-77. PubMed ID: 18790455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma.
    Percy LA; Moore SE; Qian W; Dorman J; Rabin N; Watts M; Linch DC; Yong KL
    Br J Haematol; 2012 May; 157(4):494-6. PubMed ID: 22512342
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell depletion improves outcome after autologous stem cell transplant in patients with systemic lupus erythematosus (SLE).
    Kamrava MR; Anderson EM; Kalunian K; Bashey A; Holman P; Medina B; Ball ED; Carrier E
    Bone Marrow Transplant; 2005 Jan; 35(2):205-6. PubMed ID: 15543199
    [No Abstract]   [Full Text] [Related]  

  • 12. Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery.
    Kiesel S; Pezzutto A; Körbling M; Haas R; Schulz R; Hunstein W; Dörken B
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3084-8. PubMed ID: 2565067
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autologous stem cell transplantation in multiple myeloma - contra].
    Ludwig H
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1943. PubMed ID: 19760556
    [No Abstract]   [Full Text] [Related]  

  • 14. Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma.
    Kiefer T; Krüger WH; Montemurro M; Schüler F; Hirt C; Pasold R; Niederwieser D; Schwenke M; Dölken G
    Transfusion; 2008 Dec; 48(12):2624-8. PubMed ID: 18801020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism, prevention, and restoration of immunologic aging.
    Makinodan T
    Birth Defects Orig Artic Ser; 1978; 14(1):197-212. PubMed ID: 24485
    [No Abstract]   [Full Text] [Related]  

  • 16. Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
    Crocchiolo R; Chabannon C; El-Cheikh J; Esterni B; Lemarié C; Fürst S; Castagna L; Bouabdallah R; Ladaique P; Coso D; Schiano JM; Stoppa AM; Rey J; Ivanov V; Aurran T; Faucher C; Blaise D; Calmels B
    Leuk Lymphoma; 2013 Feb; 54(2):417-20. PubMed ID: 22702654
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
    Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M
    J Clin Oncol; 2009 Oct; 27(30):5001-7. PubMed ID: 19720903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
    Testa U
    Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second stem cell transplants for multiple myeloma. If at once you don't succeed, should we really try, try again?
    Giralt S
    Biol Blood Marrow Transplant; 2012 May; 18(5):658-9. PubMed ID: 22421242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.